En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras. En esta serie de videos los Doctores Fernando Diaz, Luis Raez, Luis Corrales, Estelamari Rodriguez y Alberto Chiappori presentan el Panel de Discusión donde hablan sobre temas relevantes del cáncer de pulmón. Click aquí para ver la playlist completa.
En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras. En esta serie de videos los Doctores Fernando Diaz, Luis Raez, Luis Corrales, Estelamari Rodriguez y Alberto Chiappori presentan el Panel de Discusión donde hablan sobre temas relevantes del cáncer de pulmón. Click aquí para ver la playlist completa.
The board and staff at the Global Resource for Advancing Cancer Education (GRACE) are very pleased to announce the appointment of Nancy Iler Sladicka, Ph.D. as President of the Board of Directors effective November 3, 2023. In this role, Nancy will guide the strategic priorities of the organization and preside over the Board meetings, working closely with Amy Bickleman, Executive Director, and Matt Tan, Vice President. Nancy brings over 25 years of experience in healthcare communications...
En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras. En esta serie de videos los Doctores Fernando Diaz, Luis Raez, Luis Corrales, Estelamari Rodriguez y Alberto Chiappori presentan el Panel de Discusión donde hablan sobre temas relevantes del cáncer de pulmón. Click aquí para ver la playlist completa.
This series includes videos from the breakout sessions presented by Dr. Stephen Liu, including the following topics: Safety and Toxicity of Selpercatinib Versus Pralsetinib The Future of RET+ NSCLC Treatment NTRK+ NSCLC: Treatment Options and Side Effects NRG1 Fusions: Treatment Options To watch the complete playlist click here.
The September 2023 Blood Cancer OncTalk has now ended. Videos are available OnDemand! The full unedited versions of the September 2023 Blood Cancer OncTalk, are now available OnDemand. These topics will be edited and offered as shorter videos in the coming weeks. The full videos are available on our YouTube channel via this link: https://youtube.com/playlist?list=PLWsyUmdjLXhG4km7yALHmLjQSeUQg-36x ALL Available Slides are found under 'Documents Available for Download' on the left sidebar of the...
This series includes videos from the breakout sessions presented by Dr. Stephen Liu and Dr. Misako Nagasaka, including the following topics: Treatments and Study Data for Patients with ALK+ NSCLC Treatment Options & Study Data for Patients with ROS1+ NSCLC Rare Fusions in NSCLC: RET RET Fusion Treatment: Selpercatinib RET Fusion Treatment: Pralsetinib To watch the complete playlist click here.
This next series of videos from the Q&A sessions includes the following videos: Q&A: What Are the Platform Options for SBRT? Why Some Patients Remain on TKIs Without Acquiring Resistance? High PD-L1:Wait for Genetic Testing Results Before Treatment? To watch the complete playlist click here.
In this series of videos from the Q&A sessions, the following videos are available for viewing: Q&A: Should Biomarker Testing Be Performed on Patients with Squamous Cell Carcinoma? Resistance on Targeted Therapy: Questions Patients Should Ask What Are Some Local Therapy Options for Patients with NSCLC? Q&A: What Can Patients Do to Close the Biomarker Testing Gap? Q&A: What Do We Know About Prevention and Causes of Lung Cancer? To watch the complete playlist click here.